HALISTER: EON Plans to Pay Out 40%-60% of Underlying Net Income

EON Plans to Pay Out 40%-60% of Underlying Net Income

(Bloomberg) -- EON plans to pay out dividend of 40%-60% of underlying net income.
  • Forecasts 2016 underlying net income of EU600m-EU1b, excluding Uniper
    • Sees Ebita of EU4.6b-EU5b
    • Sees Ebit EU2.7b-EU3.1b
  • Intends to list ~53% of Uniper shares on stock market later this year
  • Spinoff is “logical response” to two energy worlds
  • NOTE: EON to host capital markets day in London today for itself and Uniper, the power company it is spinning off
Alert: HALISTER
Source: BFW (Bloomberg First Word)

Tickers
EOAN GR (E.ON SE)

To de-activate this alert, click here

UUID: 7947283

HALISTER: Diamond’s Atlas Mara Exploring Combination With Barclays Africa

Diamond’s Atlas Mara Exploring Combination With Barclays Africa

(Bloomberg) -- Atlas Mara has had discussions with a consortium of investors that is exploring an acquisition of Barclays’ stake in Barclays Africa and a potential combination of Atlas Mara with Barclays Africa.
  • Members of the consortium include Atlas Merchant Capital, founded by Bob Diamond, and the Mara Group, founded by Ashish J. Thakkar
  • No assurance that transactions will be completed
Link to Statement:Link
Alert: HALISTER
Source: BFW (Bloomberg First Word)

Tickers
BARC LN (Barclays PLC)
ATMA LN (Atlas Mara Ltd)
BGA SJ (Barclays Africa Group Ltd)

People
Ashish Thakkar (Mara Group)
Robert Diamond (Atlas Merchant Capital LLC)

To de-activate this alert, click here

UUID: 7947283

HALISTER: Bayer Beats Estimates as Demand for Latest Drugs Stays Buoyant

Bayer Beats Estimates as Demand for Latest Drugs Stays Buoyant

Alert: HALISTER
Source: BN (Bloomberg News)

Tickers
BAYN GR (Bayer AG)
1COV GR (Covestro AG)
REGN US (Regeneron Pharmaceuticals Inc)
4536 JP (Santen Pharmaceutical Co Ltd)

People
Marijn Dekkers (Bayer AG)
Werner Baumann (Bayer HealthCare AG)

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283

HALISTER: Bayer 1Q Ebitda Ex-Items Beats Estimates; Confirms 2016 Outlook

Bayer 1Q Ebitda Ex-Items Beats Estimates; Confirms 2016 Outlook

(Bloomberg) -- Bayer 1Q Ebitda before special items EU3.4b, est. EU3.1b.
  • 1Q sales EU11.9b, est. EU12.1b
  • 1Q core EPS from continuing operations EU2.37, est. EU2.17
  • Confirms 2016 outlook
  • NOTE: new organizational structure effective Jan. 1; operations now managed in 3 divisions -- Pharmaceuticals, Consumer Health and Crop Science -- and the Animal Health business unit
  • NOTE 2016 outlook (Feb. 25): sees further growth in sales and earnings this year
  • NOTE yday: Covestro 1Q Adj. Ebitda Beat Est., Confirmed 2016 Forecast
  • Investor call at ~2pm
  • Preview
  • Statement
Alert: HALISTER
Source: BFW (Bloomberg First Word)

Tickers
BAYN GR (Bayer AG)

Topics
Plastics

To de-activate this alert, click here

UUID: 7947283